ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
about
Clinical management of localized colon cancer with capecitabineNew trends in molecular and cellular biomarker discovery for colorectal cancerThe Immunogenicity of Colorectal Cancer in Relation to Tumor Development and TreatmentTreatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancerAdvanced imaging of colorectal cancer: From anatomy to molecular imagingTumor Budding: The Name is EMT. Partial EMTColorectal cancer tumour markers and biomarkers: Recent therapeutic advancesAdjuvant chemotherapy for rectal cancer: Is it needed?Biomarkers of Angiogenesis in Colorectal CancerTreatment of colorectal cancer in the elderlyClinical management of regorafenib in the treatment of patients with advanced colorectal cancerQuality assurance in the treatment of colorectal cancer: the EURECCA initiativeAcquired resistance to EGFR-targeted therapies in colorectal cancerTreatment of metastatic colorectal cancer: focus on panitumumabHow to select the optimal treatment for first line metastatic colorectal cancerThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careCancer and liver cirrhosis: implications on prognosis and managementCan we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an exampleAnemia and iron deficiency in gastrointestinal and liver conditionsMechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancerConsensus report from the 7th International Forum for Liver Magnetic Resonance ImagingTumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab TherapymiR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cellsSecond-line systemic therapy for metastatic colorectal cancer.Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised coLocally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulationsPatient considerations in metastatic colorectal cancer - role of panitumumab.Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.Age-adjusted charlson comorbidity index score as predictor of prolonged postoperative ileus in patients with colorectal cancer who underwent surgical resection.Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.Neoadjuvant therapy before surgical treatmentAdjuvant chemotherapyB cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancerCorrelating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.Prognostic and predictive significance of MSI in stages II/III colon cancer.Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver MetastasesPrognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen.Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
P2860
Q24611758-1A20D719-21FA-4D3D-9ACB-06BCE89BA531Q26739049-B4B2DFD3-3585-4C74-9136-84187F61A490Q26745580-F039EAAA-050B-4636-A4DA-C73800E6B713Q26747335-E260DFAB-85CE-4D36-8BF9-E7FE1F51F02AQ26748060-A111203D-094D-46B3-910D-6DBC3C7E6CEDQ26748136-F984FA75-42EA-478F-8D63-2AC746F14DABQ26768427-9CBBC39E-4768-4759-AAB5-0E70A7E97CE5Q26775099-BECB4ECE-F01D-45C9-93AA-D518AF11438BQ26778891-DC154B4E-E897-4504-9D1F-161AE71CC697Q26781457-0B88EA38-0971-44FB-B37F-0E49846F6234Q26821956-A451B8B3-01CC-4D7C-990F-AE238915B90AQ26998562-60B85806-BC8A-43BA-9B53-514149334999Q27022741-D10BCECB-8462-4D23-ADCB-E1D966C66075Q27022954-35371DD6-CAE1-4EB3-BB77-B485457A3C97Q27026516-BD9A8727-9500-4812-B811-B148D03B90EDQ28066460-AC1CA45C-60FD-4E39-9C09-1A6AB3E6CBF1Q28068579-7D5911E2-5FF7-4934-BC87-931DEDC51824Q28069620-C11878E2-796F-450B-9418-2D876B6EA291Q28069820-2996D7C0-AE8D-4503-B71C-28DEDFC5CEABQ28076490-250EB1FB-3E7C-471F-81FA-6CC6A52AD50EQ28088807-BF26CA77-3E51-41C7-97ED-9165EE4123D9Q28550733-7E46261B-6EC6-47CF-929C-82CEE33CA1F6Q28829677-97DB72CB-4102-43D2-9F98-F90357854E0AQ30238760-4D1BE3A8-1649-444E-943A-D0F251FB5210Q30316930-408BC617-E903-4A12-B175-4B9A33724D17Q30657649-69B2EF88-74D6-4910-9ADB-4DD95F7779FBQ31056926-C5A623CB-B97C-4FF8-AD6C-5CAB2F79E402Q33417630-EE4D14C1-086E-4427-8D52-57FC122D0B05Q33563293-47F880EA-4F3D-49CD-A87B-0016D4915C82Q33577619-68B30EBB-6B9B-446E-9A86-10AC84EC96D3Q33591352-66C0ADED-4BF9-4856-B8D8-3C413FADEB71Q33595542-4808C026-729F-4EA6-9F91-763E3F08F482Q33697924-D08F14BE-A942-4A7D-B928-B7DC8BC0E18EQ33698724-E89E43AB-03DD-4C38-A5E5-410A70F12BF4Q33721433-673C75A9-6BCC-4273-9189-8339C796C4FAQ33733088-79299119-F0BE-4CF7-AE69-D8732BA3F059Q33735239-223FBDEB-ABB7-450A-BC0A-4B0ADC83C29AQ33770802-22559E06-30D1-4496-9E45-03EC830D1126Q33778129-A16FA49C-D445-46FD-9AA1-7575D0A9DE90Q33813216-06AE87B4-0AE3-4F15-9699-2790A3E457BB
P2860
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
description
im September 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2012
@uk
name
ESMO Consensus Guidelines for ...... ch to clinical decision making
@en
ESMO Consensus Guidelines for ...... ch to clinical decision making
@nl
type
label
ESMO Consensus Guidelines for ...... ch to clinical decision making
@en
ESMO Consensus Guidelines for ...... ch to clinical decision making
@nl
prefLabel
ESMO Consensus Guidelines for ...... ch to clinical decision making
@en
ESMO Consensus Guidelines for ...... ch to clinical decision making
@nl
P2093
P2860
P50
P356
P1433
P1476
ESMO Consensus Guidelines for ...... ch to clinical decision making
@en
P2093
A Cervantes
A Meshcheryakov
B Glimelius
B Nordlinger
C J van de Velde
P2860
P304
P356
10.1093/ANNONC/MDS236
P50
P577
2012-10-01T00:00:00Z